/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
Diamyd Medical AB (publ)
DMYD | ST
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- https://www.diamyd.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Diamyd Medical AB is a clinical-stage company developing precision medicine therapies to prevent and treat autoimmune diabetes, primarily Type 1 Diabetes and Latent Autoimmune Diabetes in Adults (LADA). Its lead product candidate, Diamyd®, is an antigen-specific immunotherapy designed to preserve the body's own insulin-producing capabilities. The therapy, administered intralymphatically, targets individuals with a specific HLA genotype. Diamyd® is undergoing evaluation in the pivotal Phase 3 trial, DIAGNODE-3, and the Phase 2 prevention trial, DiaPrecise. The company is also establishing a facility for the manufacturing of its biological active ingredient, GAD65.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Diamyd Medical AB (publ).
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Diamyd Medical AB (publ) filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Diamyd Medical AB (publ) via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
